perfluorophenyl 2-(4-(ethylsulfonyl)phenyl)acetate | 1426805-26-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚酯
• 英文名称: perfluorophenyl 2-(4-(ethylsulfonyl)phenyl)acetate
• 英文别名: (2,3,4,5,6-Pentafluorophenyl) 2-(4-ethylsulfonylphenyl)acetate；(2,3,4,5,6-pentafluorophenyl) 2-(4-ethylsulfonylphenyl)acetate
• CAS: 1426805-26-6
• 化学式: C₁₆H₁₁F₅O₄S
• 分子量: 394.319
• InChiKey: ZZFFNXFPCBIANM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  26
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.19
• 拓扑面积：
  68.8
• 氢给体数：
  0
• 氢受体数：
  9

反应信息

• 作为反应物：
  描述：

  perfluorophenyl 2-(4-(ethylsulfonyl)phenyl)acetate 在 tin(II) chloride dihdyrate 、 乙醇 、 caesium carbonate 、 potassium iodide 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 100.0h， 生成 1-(2,4-dichlorophenethyl)-1H-indol-5-amine
  参考文献：
  名称：

  Discovery of Tertiary Amine and Indole Derivatives as Potent RORγt Inverse Agonists

  摘要：

  A novel series of tertiary amines as retinoid-related orphan receptor gamma-t (ROR gamma t) inverse agonists was discovered through agonist/inverse agonist conversion. The level of ROR gamma t inhibition can be enhanced by modulating the conformational disruption of H12 in ROR gamma t LBD. Linker exploration and rational design led to the discovery of more potent indole-based ROR gamma t inverse agonists.

  DOI：

  10.1021/ml4003875
• 作为产物：
  描述：

  五氟苯酚 、 2-(4-(乙基磺酰基)苯基)乙酸 在 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 以 二氯甲烷 为溶剂， 以53.4%的产率得到perfluorophenyl 2-(4-(ethylsulfonyl)phenyl)acetate
  参考文献：
  名称：

  Discovery of Tertiary Amine and Indole Derivatives as Potent RORγt Inverse Agonists

  摘要：

  A novel series of tertiary amines as retinoid-related orphan receptor gamma-t (ROR gamma t) inverse agonists was discovered through agonist/inverse agonist conversion. The level of ROR gamma t inhibition can be enhanced by modulating the conformational disruption of H12 in ROR gamma t LBD. Linker exploration and rational design led to the discovery of more potent indole-based ROR gamma t inverse agonists.

  DOI：

  10.1021/ml4003875

文献信息

• [EN] NOVEL COMPOUNDS<br/>[FR] NOUVEAUX COMPOSÉS
  申请人：GLAXO GROUP LTD

  公开号：WO2013029338A1

  公开（公告）日：2013-03-07

  Disclosed are novel retinoid-related orphan receptor gamma (RORy) modulators and their use in the treatment of diseases mediated by RORy.

  揭示了一种新型的视黄醇相关孤儿受体γ（RORγ）调节剂，以及它们在治疗由RORγ介导的疾病中的用途。
• Discovery of Biaryl Amides as Potent, Orally Bioavailable, and CNS Penetrant RORγt Inhibitors
  作者：Yonghui Wang、Wei Cai、Yaobang Cheng、Ting Yang、Qian Liu、Guifeng Zhang、Qinghua Meng、Fangbin Han、Yafei Huang、Ling Zhou、Zhijun Xiang、Yong-Gang Zhao、Yan Xu、Ziqiang Cheng、Sijie Lu、Qianqian Wu、Jia-Ning Xiang、John D. Elliott、Stewart Leung、Feng Ren、Xichen Lin

  DOI：10.1021/acsmedchemlett.5b00122

  日期：2015.7.9

  A novel series of biaryl amides was identified as ROR gamma t inhibitors through core replacement of a starting hit 1. Structure activity relationship exploration on the biaryl moiety led to discovery of potent ROR gamma t inhibitors with good oral bioavailability and CNS penetration. Compounds 9a and 9g demonstrated excellent in vivo efficacy in EAE mice dose dependently with once daily oral administration.